ClinicalTrials.gg
RecruitingNCT06730074PDUpdated Dec 17, 2024

A Novel Robotic System for Motor-cognitive Exercise for Patients With Parkinson's Disease

An interventional study of Using a gamified rehabilitation system in a sitting position involving robots and music for the benefit of individuals with Parkinson's disease (PD) in Parkinson Disease, Idiopathic, sponsored by Adi Negev-Nahalat Eran. Recruiting at 1 site in Israel. Open to participants aged 50 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-12-17.

Sponsored by Adi Negev-Nahalat Eran · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 8 months ago, but the record still lists the study as recruiting.
  • Started Dec 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
50 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 124 studies in Parkinson Disease with a site in Israel — 17 open to participants now, 24 under way, 1 of them phase 3. Parkinson Disease · Israel.

Planned enrollment
72nd of 84
15 · median 60
Started
2024
with 3 others
No phase
28 of 124
4 open now
Primary completion
2025-03
later than 5 of 23 live
Registered
117th of 124
by date

Among the 124 studies in Parkinson Disease with a site in Israel, this one is the 72nd largest by planned enrollment of the 84 interventional ones that give a count, is one of 4 that started in 2024, is one of 28 with no phase, reaches primary completion later than 5 of the 23 other live ones, and was the 117th registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

17 of the 124 studies in Parkinson Disease with a site in Israel are open now. Recruiting first, the newest first:

11 more — sign in →

All 17 open studies →

A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 50 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 124 studies in Parkinson Disease with a site in Israel, or all of them as a file.
02

Study summary

The objective of this study is to test a gamified rehabilitation system in a sitting position involving robots and music for the benefit of individuals with Parkinson's disease (PD). This pilot experiment will involve the collection of both subjective user evaluation measures and objective motor and cognitive measures.

Read the detailed description

Participants \& Protocol:

Recruitment: Advertising ads in movement disorders units in hospitals and medical centers in the south, as well as through the help of the Parkinson's Association.

The study will be conducted with 15 PD patients, aged 50-75, at the Adi Negev Clinic. Each patient will use the robotic system five times, with each session lasting 30 minutes. The intervention plan incorporates principles of effective rehabilitation practice, including repeated practice, goal-oriented practice, variable difficulty, rhythmic cueing, and social interaction. Before the research begins, participants will sign an informed consent form.

Baseline and Pre-Post Tests:

Assessments including the MoCA, demographic data, clinical data, Color Trails Test (CTT), motor UPDRS, Box \& Blocks Test, and Cognitive Reserve Index Questionnaire (CRIq) will be collected before the first session by an occupational or physical therapist. After the fifth session, post-intervention assessments will include motor UPDRS, Box \& Blocks Test, CTT, System Usability Scale (SUS), Intrinsic Motivation Inventory (IMI), and a satisfaction questionnaire.

Hypothesis:

It is hypothesized that motor and cognitive training using the robots will improve the patients' clinical symptoms, as evidenced by pre-post test results.

Novelty \& Impact:

This is the first socially assistive robotic platform developed specifically for people with PD. If successful, this platform could be incorporated into the clinical toolbox at Adi Negev and other centres. Additionally, this study will be the first to use the Cognitive Reserve Index Questionnaire (CRIq) in Hebrew for people with PD. The potential impact of this project is twofold: testing a new rehabilitation tool and a screening tool for PD patients.

03

Conditions studied

  • Parkinson Disease, Idiopathic

Browse trials for

Keywords

  • Parkinson-disease
  • SAR
  • Rehabilitation
  • Motor-Cognitive
  • PD
04

Who can participate

Ages eligible
50 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Signing the form
  • Men and women in ages 50-75
  • Hebrew speakers
  • Have Idiopathic Parkinson's disease
  • Hoehn and Yahr 3 and below
  • Moca test 23 and above

Exclusion criteria

Exclusion Criteria:

  • Patients with Parkinson's plus syndromes
  • PD patients who suffer from unrelated neurological symptoms.
  • Orthopedic problems of the upper limb
  • Recent surgery conducted on the upper limb
  • Uncorrected vision problems
  • Uncorrected severe hearing loss
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Gamified rehabilitation system involving robot for individuals with Parkinson's

    We will run a robotic exercise game with 15 PD patients who will use the system in a sitting position. Each patient will use the system 5 times, each time for 30 min. Principles of effective rehabilitation practice such as repetitive practice, goal-oriented practice, variable difficulty, rhythmic cueing, and social interaction are implemented in our design

    Device: Using a gamified rehabilitation system in a sitting position involving robots and music for the benefit of individuals with Parkinson's disease (PD)

Interventions

  • DeviceUsing a gamified rehabilitation system in a sitting position involving robots and music for the benefit of individuals with Parkinson's disease (PD)

    This is the first socially assistive robotic platform developed specifically for people with PD. If successful, this platform could be incorporated into the clinical toolbox at Adi Negev and other centres.

06

What researchers measure

Primary outcomes

  1. level of engagement

    We will ask participants to rate their perceived level of engagement with the platform.

    Time frame: 2 Mon

Secondary outcomes

  1. improvement in UPDRS

    We will perform post-intervention assessments which include motor UPDRS (Unified Parkinson Disease Rating Scale)

    Time frame: 4 Mon

  2. improvement in fine motor coordination

    We will perform post-intervention assessments which include Box and Blocks Test for fine motor coordination.

    Time frame: 4 Mon

  3. improvement in CTT (Color Trail Test)

    We will perform post-intervention assessments which include CTT (Color Trail Test) for executive functions.

    Time frame: 4 Mon

  4. Testing the usability of use of the system

    We will perform post-intervention assessments which include System Usability Scale (SUS).

    Time frame: 4 Mon

  5. Measuring the motivation to use the system

    We will perform post-intervention assessments which include the Intrinsic Motivation Inventory (IMI).

    Time frame: 4 Mon

07

Study locations

1 of 1 sites recruiting
  • Adi Negev
    Ofakim, South, Israel
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for Mar 2025, 3 months after the start.

Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 3 months is below that.

Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 24, 2024
First posted
Dec 12, 2024
StartActual
Dec 12, 2024
Primary completionEst.
Mar 2025
CompletionEst.
Aug 2025
Last update
Dec 17, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06730074
Lead sponsor
Adi Negev-Nahalat Eran
Responsible party
Ilanit Baum-Cohen (Occupational Therapist, Adi Negev-Nahalat Eran) — Principal investigator
First posted
Dec 12, 2024
Start date
Dec 12, 2024
Primary completion
Mar 2025 (estimated)
Completion
Aug 2025 (estimated)
Last update
Dec 17, 2024

Study contacts

Dori Katz, Medical Doctor
Contact
dorik@adi-il.org
+972 52 268 9046
Ilanit Baum Cohen, Msc. OT
Contact
ilanit.nit@gmail.com
+972 52 8807 503

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion